2-[18F]fluoro-A-85380, an in vivo tracer for the nicotinic acetylcholine receptors

Nuclear Medicine and Biology

Volumn 25, Issue 7, 1998, Pages 599-603

  Horti, Andrew G ^a   Scheffel, Ursula ^b   Koren, Andrei O ^a   Ravert, Hayden T ^b   Mathews, William B ^b   Musachio, John L ^b   Finley, Paige A ^b   London, Edythe D ^a   Dannals, Robert F ^b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

A 85380 derivative; Acetylcholine receptor; Brain distribution; Nicotinic receptor; PET; Pharmacology; Radiotracer

Indexed keywords

2 FLUORO 3 (AZETIDINYLMETHOXY)PYRIDINE F 18; 3 (2 AZETIDINYLMETHOXY)PYRIDINE; FLUORINE 18; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG; AZETIDINE DERIVATIVE; FLUORINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; BRAIN MAPPING; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; HORMONE RECEPTOR INTERACTION; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; LIGAND BINDING; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RECEPTOR DENSITY; ANIMAL; BINDING COMPETITION; DRUG EFFECT; MALE; METABOLISM; TISSUE DISTRIBUTION;

ANIMALS; AZETIDINES; BINDING, COMPETITIVE; FLUORINE RADIOISOTOPES; INJECTIONS, INTRAVENOUS; MALE; MICE; RECEPTORS, NICOTINIC; TISSUE DISTRIBUTION;

EID: 0031593889     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00031-6     Document Type: Article

References (31)

1. Abreo M.A., Lin N.-H., Garvey D.S., Gunn D.E., Hettinger A.-M., Wasicak J.T., et al. Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. J. Med. Chem. 39:1996;817-825.
2. 3H]l-nicotine in the mouse brain. Life Sci. 44:1989;1123-1132.
3. Decker M.W., Brioni J.D., Bannon A.W., Arneric S.P. Diversity of neuronal nicotinic acetylcholine receptors Lessons from behavior and implications for CNS therapeutics . Life Sci. 56:1995;545-570.
4. Ding Y-S, Gatley S.J., Fowler J.S., Volkow N.D., Aggarwal D., Logan J., et al. Mapping nicotinic acetylcholine receptors with PET. Synapse. 24:1996;403-407.
5. Fisher M., Huangfu D., Shen T.Y., Guyenet P.G. Epibatidine, an alkaloid from the poison frog Epipedobates tricolor, is a powerful ganglionic depolarizing agent. J. Pharm. Exper. Ther. 270:1994;702-707.
6. 3H]cytisine. Life Sci. 54:1994;1883-1890.
7. Flicker D.R.L., Watkins D.L., Fisher S.K., Bartus R.T. Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to cerebral cortex in rat. Pharmacol. Biochem. Behav. 18:1983;973-981.
8. Gersanich V., Peng X., Wang F., Wells G., Anand R., Fletcher S., et al. Comparative pharmacology of epibatidine A potent agonist for neuronal nicotinic acetylcholine receptors . Mol. Pharmacol. 48:1995;774-782.
9. Henningfield J.E., Woodson P.P. Dose-related actions of nicotine on behavior and physiology Review and implications for replacement therapy for nicotine dependence . J. Subst. Abuse. 1:1989;301-317.
10. 18F]A-85380) . J. Label. Compds. Radiopharm. 41:1998;309-318.
11. 11C]-N-methylated analogs of epibatidine as tracers for PET studies of nicotinic acetylcholine receptors. J. Med. Chem. (submitted for publication).
12. 18F]FPH for PET imaging of nicotinic acetylcholine receptors. J. Nucl. Med. 38:1997;1260-1265.
13. 18F]-(±)-exo-2-(2-fluoro-5-pyridyl)-7-azabi cyclo[2.2.1]heptane, a radioligand for in vivo labeling and imaging of central nicotinic acetylcholine receptors. J. Nucl. Med. 37:(suppl.):1996;11P.
14. 18F]fluoro-5-pyridyl)-7-azabicyclo[2.2.1]heptane . J. Label. Compd. Radiopharm. 38:1996;355-365.
15. Irle E., Markowitsch H.J. Basal forebrain-lesioned monkeys are severely impaired in tasks of association and recognition memory. Ann. Neurol. 14:1985;1025-1032.
16. Levin E.D., Rose J.E. Acute and chronic nicotinic interactions with dopamine systems and working memory performance. Ann. N. Y. Acad. Sci. 757:1995;245-252.
17. 3H]epibatidine. Eur. J. Pharm. 278:1995;R1-R2.
18. London E.D., Ball M.J., Waller S.B. Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia. Neurochem. Res. 14:1989;745-749.
19. 3H]nicotine binding sites in the rat brain. Neurosci. Lett. 53:1985;179.
20. Maziere M., Berger G., Masse R., Phimmer D., Comar D. The in vivo distribution of carbon-11-labelled (-)-nicotine in animals A method suitable for use in man . Remond A., Izard C. Electrophysiological Effects of Nicotine. 1979;31-47 Elsevier, Amsterdam.
21. 18F]Norchlorofluoroepibatidine (NFEP) Preclinical toxicological studies . J. Nucl. Med. 38:(suppl.):1997;287P. (Abstract).
22. Nyback H., Nordberg A., Langstrom B., Halldin C., Ahlin A., Swahn C.G., et al. Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography. Prog. Brain Res. 79:1989;313-319.
23. Pert A. Cholinergic and catecholaminergic modulation of nociceptive reactions Interactions with opiates . Akil H., Lewis J.W. Pain and Headache, Neurotransmitters and Pain Control. 1987;1-63 Karger, Basel.
24. Scheffel U., Taylor G.F., Kepler J.A., Carroll F.I., Kuhar M.J. In vivo labeling of neuronal nicotinic acetylcholine receptors with radiolabeled isomers of norchloroepibatidine. Neuroreport. 6:1995;2483-2488.
25. Scheffel U., Ricaurte G.A. Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity A presynaptic serotonergic positron emission tomography ligand? Brain Res. 527:1990;89-95.
26. Spande T.F., Garraffo H.M., Edwards M.W., Yeh H.J.C., Panell L., Daly J.W. Epibatidine A novel (chloropyridyl)azabicycloheptane with potent analgesic activity from an Ecuadorian poison frog . J. Am. Chem. Soc. 114:1992;3475-3478.
27. 2 nicotinic acethylcholine receptor ligand . Neuropharmacology. 35:1996;725-734.
28. Villemagne V.L., Horti A., Scheffel U., Ravert H.T., Finley P., London E.D., et al. Imaging nicotinic acetylcholine receptors in baboon brain by PET. J. Nucl. Med. 37:(suppl.):1996;11P.
29. Villemagne V.L., Horti A., Scheffel U., Ravert H.T., Finley P., Clough D.J., et al. Imaging nicotinic acetylcholine receptors with PET and [F-18]-FPH, a [F-18]-labeled analogue of epibatidine. J. Nucl. Med. 38:1997;1737-1741.
30. Whitehouse P.J., Martino A.M., Antuono P.G., Lowenstein P.R., Coyle J.T., Price D.L., et al. Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res. 371:1986;146-151.
31. Xiao Y., Meyer E.L., Houghtling R.A., Thomson J.M., Kellar K.J. Stable expression of rat nicotinic acethylcholine receptor subtypes in mammalian cells. Soc. Neurosci. Abstr. 22:1996;1043.